#ForexChief #Profit #Pfizer #Market #forexnews #Stock #worldnews #Johnson #AstraZeneca #nyse #nasdaq⠀
🦠 The World is preparing for a new pandemic, and the market – for purchases
⠀
At the Davos Forum, politicians, economists, doctors and participants simply interested in this topic discussed the threat of a new «disease X», which, according to WHO forecasts, could be 20 times more dangerous than COVID-19. There is no real virus yet, but everyone has drawn their conclusions.
⠀
The term «Disease X» refers to a pathogen unknown to mankind, which (hypothetically!) under certain circumstances could cause an epidemic of international proportions. Specialists – morally, financially and technically – have been preparing for such a scenario since 2018.
⠀
In 2019, SARS-CoV-2 was appointed to this role, but now the coronavirus has become an ongoing public health problem and is no longer considered an international health emergency.
⠀
In addition to new strains of COVID-19, there are no less dangerous viral hemorrhagic fevers, the Zika virus, the Ebola virus, etc., and this infection appears regularly. Based on the results of the discussion, the statement that the WHO has all the necessary capabilities to counter biological threats of any nature can be considered positive information. We are simply asked to believe it.
⠀
What does this mean for the market?
⠀
Barring fantastic global conspiracy theories, the idea of a «new virus» could stimulate an influx of investment in pharmaceutical companies to ensure pandemic preparedness.
⠀
So far, Pfizer Inc (NYSE: PFE), Johnson & Johnson (NYSE: JNJ), AstraZeneca PLC (LSE: AZN), drug distributor McKesson Corporation (NYSE: MCK), biotech concerns Vertex Pharmaceuticals (NASDAQ: VRTX) and Organon & Co (NYSE: OGN) and other monsters of the medical industry have not reacted in any way, but the most active speculators are already looking for new targets.
⠀
What shares would you buy?
⠀
Profits to y’all!